KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) EBITDA Margin: 2017-2025

Historic EBITDA Margin for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to 14.69%.

  • Elanco Animal Health's EBITDA Margin rose 818.00% to 14.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.85%, marking a year-over-year increase of 3791.00%. This contributed to the annual value of -34.13% for FY2024, which is 3664.00% up from last year.
  • Per Elanco Animal Health's latest filing, its EBITDA Margin stood at 14.69% for Q3 2025, which was down 17.52% from 17.81% recorded in Q2 2025.
  • Elanco Animal Health's 5-year EBITDA Margin high stood at 20.87% for Q1 2025, and its period low was -148.31% during Q3 2023.
  • Over the past 3 years, Elanco Animal Health's median EBITDA Margin value was -41.74% (recorded in 2024), while the average stood at -33.65%.
  • In the last 5 years, Elanco Animal Health's EBITDA Margin plummeted by 9,802bps in 2023 and then surged by 15,482bps in 2024.
  • Quarterly analysis of 5 years shows Elanco Animal Health's EBITDA Margin stood at -57.10% in 2021, then skyrocketed by 259bps to -54.52% in 2022, then tumbled by 761bps to -62.13% in 2023, then spiked by 801bps to -54.12% in 2024, then soared by 818bps to 14.69% in 2025.
  • Its EBITDA Margin stands at 14.69% for Q3 2025, versus 17.81% for Q2 2025 and 20.87% for Q1 2025.